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Abstract
Genetic redundancy, whereby two genes carry out seemingly overlapping functions, may in large part be attributable to the
intricacy and robustness of genetic networks that control many developmental processes. We have previously described a
complex set of genetic interactions underlying foregut development in the nematode Caenorhabditis elegans. Specifically,
LIN-35/Rb, a tumor suppressor ortholog, in conjunction with UBC-18–ARI-1, a conserved E2/E3 complex, and PHA-1, a novel
protein, coordinately regulates an early step of pharyngeal morphogenesis involving cellular re-orientation. Functional
redundancy is indicated by the observation that lin-35; ubc-18 double mutants, as well as certain allelic combinations of pha-
1 with either lin-35 or ubc-18, display defects in pharyngeal development, whereas single mutants do not. Using a
combination of genetic and molecular analyses, we show that sup-35, a strong recessive suppressor of pha-1–associated
lethality, also reverts the synthetic lethality of lin-35; ubc-18, lin-35; pha-1, and ubc-18 pha-1 double mutants. SUP-35, which
contains C2H2-type Zn-finger domains as well as a conserved RMD-like motif, showed a dynamic pattern of subcellular
localization during embryogenesis. We find that mutations in sup-35 specifically suppress hypomorphic alleles of pha-1 and
that SUP-35, acting genetically upstream of SUP-36 and SUP-37, negatively regulates pha-1 transcription. We further
demonstrate that LIN-35, a transcriptional repressor, and UBC-18–ARI-1, a complex involved in ubiquitin-mediated
proteolysis, negatively regulate SUP-35 abundance through distinct mechanisms. We also show that HCF-1, a C. elegans
homolog of host cell factor 1, functionally antagonizes LIN-35 in the regulation of sup-35. Our cumulative findings piece
together the components of a novel regulatory network that includes LIN-35/Rb, which functions to control organ
morphogenesis. Our results also shed light on general mechanisms that may underlie developmental genetic redundancies
as well as principles that may govern complex disease traits.
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Introduction
Genetic redundancy describes the phenomenon in which the
combined inactivation of two distinct genes produces a phenotype
that is not observed in either single mutant. One of the current
challenges facing geneticists and developmental biologists alike is
to understand the underlying bases of genetic redundancy at the
molecular level. This may in many cases prove to be a difficult
undertaking given the complexity of regulatory networks and the
many difficulties associated with establishing clear connections
between seemingly disparate genes. Nonetheless, redundancy is an
issue of great biological importance, as evidenced in C. elegans,
where most genes fail to show obvious or highly penetrant
phenotypes following inhibition or inactivation [1–3].
To date, the most intensively studied case of genetic redundancy
in C. elegans involves the Synthetic Multivulval (SynMuv) genes (for
a review, see [4]. The SynMuv genes can in most cases be divided
into two principal non-overlapping groups, termed class A and
class B [5]. Inhibition of individual class A or class B genes does
not typically alter normal patterns of vulval cell induction in
hermaphrodites. In contrast, the combined loss in activity of any
class A–class B gene pair leads to the ectopic induction of vulval
tissue (the Muv phenotype). In addition, a class C group of
SynMuv genes has recently been identified; mutations in class C
genes are synthetic with mutations in both class A and class B
SynMuv genes [6].
Extensive work has shed considerable light on the role of
SynMuv genes in vulval development. Namely, most class A and B
genes act within the hypodermis, a multi-nucleate epidermal tissue
that lies adjacent to the developing vulval precursor cells (VPCs),
where they redundantly inhibit the expression of the EGF-like
ligand, LIN-3 [7]. Secreted LIN-3 induces vulval cell development
through activation of a conserved EGFR–Ras–Map kinase
pathway in the VPCs [8]. Thus, in the absence of both class A
and class B SynMuv activity, abnormally high levels of LIN-3,
secreted by the hypodermis, leads to the hyperinduction of vulval
cell fates.
Based on studies in C. elegans, Drosophila, and mammals, the large
majority of proteins encoded by the class B SynMuv gene family
function within a conserved set of structurally related transcrip-
tional repressor complexes that include DRM (Dp, Rb and MuvB)
and NuRD (nucleosome remodeling and histone deacetylase;
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these complexes are LIN-35, the sole C. elegans Retinoblastoma
protein (pRb) family ortholog, and EFL-1, a member of the E2F
family of transcription factors [10–12]. Similar to its role in other
systems, LIN-35 acts in large part to mediate the transcriptional
repression of E2F target genes [13]. Nevertheless, the precise
means by which class A and B SynMuv genes influence the
expression of LIN-3 in the hypodermis is currently unclear.
Furthermore, the precise molecular functions of class A genes are
presently unknown, although a role in transcription has been
proposed [4].
We have previously described a forward genetic screen for
identifying mutations that show strong synthetic genetic interac-
tions in conjunction with the loss of lin-35 [14]. This and other
work has led to the identification of a diverse array of redundant
functions for LIN-35 including roles in cell cycle control [14,15],
cell fate specification [16], asymmetric cell division [17], larval
growth [18,19], fertility [16,20], organogenesis [20,21], and organ
function [22]. In addition, LIN-35, along with a number of other
class B SynMuv genes, has been shown to function non-
redundantly in the control of transgene expression [23], RNAi
[24,25], germline and somatic sex-linked apoptosis [26,27],
ribosome biogenesis [28], and the somatic silencing of germline
gene expression [13,25].
In our current work, we have sought to understand the
mechanistic basis for the synthetic genetic interactions observed
between lin-35 and two mutations previously identified by our
screen, ubc-18 and pha-1 [21,29]. Both lin-35; ubc-18 and lin-35;
pha-1 double mutants arrest predominantly as L1 larvae and
display severe defects in pharyngeal morphogenesis. Furthermore,
ubc-18 pha-1 double mutants are also synthetically lethal, indicating
that the functions of these three genes are interconnected [29].
Notably, the genetic interactions between pha-1 and lin-35 or ubc-
18 can be observed only under conditions in which pha-1 activity is
weakly compromised. This is because strong loss-of-function
mutations in pha-1 are themselves lethal, and arrested pha-1
mutant animals display defects in pharyngeal and body morpho-
genesis [30].
Through an analysis of the suppressor mutation sup-35,w e
demonstrate that SUP-35 acts as an inhibitor of pha-1 transcrip-
tion. Furthermore, we show that LIN-35 and UBC-18 act through
distinct mechanisms to negatively regulate SUP-35 expression.
Thus, the simultaneous loss of lin-35 and ubc-18 leads to increased
levels of SUP-35, which in turn trigger a reduction in the levels of
PHA-1. These findings provide a straightforward explanation for
the observed genetic interactions between these genes and more
generally provide further insight into the nature of mechanisms
that can underlie genetic redundancies.
Results
sup-35 encodes a Zn-finger protein with homology to
RMD family members
As described in the Introduction, lin-35 mutations are strongly
synthetic with hypomorphic mutations that affect the pha-1 locus,
leading to strong pharyngeal morphogenesis defects [29]. In
addition, recessive mutations in three genetic loci (sup-35, sup-36,
and sup-37) were demonstrated to strongly suppress the embryon-
ic- and larval-lethal phenotype of strong loss-of-function pha-1
mutants [31]. We have previously shown that mutations in sup-36
and sup-37 efficiently suppress the synthetic lethality of lin-35; pha-
1 and lin-35; ubc-18 double mutants [29]. As described below,
these and other related synthetic genotypes were also suppressed
by mutations in sup-35. Thus, to learn more about the interplay
between these various factors and their roles in pharyngeal
development, we sought to identify the sup-35 locus.
Previous mapping data had placed sup-35 on LGIII, ,0.1 cM
to the left of the pha-1 locus [31]. To identify the gene encoding
sup-35, we carried out RNAi feeding of 384 clones corresponding
to genes in the region proximal to pha-1. Two clones, which target
the highly related genes Y48A6C.1 and Y48A6C.3, were identified
that strongly suppress the embryonic lethality of pha-1(e2123ts)
mutants (referred to hereafter as pha-1(ts)) at the non-permissive
temperature of 25uC (Table 1). These RNAi clones also suppress
the less severe L1 larval-arrest phenotype of pha-1(ts) mutants at
intermediate temperature of 20uC (data not shown). Because
Y48A6C.1 and Y48A6C.3 share extensive sequence homology (an
878-bp segment present in both genes is 99% identical), each
RNAi construct is expected to inhibit both gene products through
off-target effects; no additional off targets for these RNAi
constructs are predicted. These results suggest that sup-35 may
be encoded by either Y48A6C.1 or Y48A6C.3. However, an
additional RNAi construct that is expected to target Y48A6C.1,
but not Y48A6C.3, failed to suppress pha-1(ts) mutants at 25uC,
suggesting that Y48A6C.3 is the relevant locus (data not shown).
Additional support for Y48A6C.3 as the affected locus was
provided by sequencing both Y48A6C.1 and Y48A6C.3 in sup-
35(e2223) pha-1(ts) double mutants. We detected a T-to-A
transversion at nucleotide position 19 of the Y48A6C.3 open
reading frame, resulting in the conversion of a cysteine to a serine
at amino acid position seven. In contrast, we failed to identify any
differences in the Y48A6C.1 locus between the published wild-
type (N2) and sup-35(e2223) mutant sequences. Furthermore, we
identified sequence alterations in Y48A6C.3 in five previously
isolated alleles of sup-35 [31] as well as in 14 additional alleles
identified by our laboratory. A summary of our sequence analysis
is shown in Figure 1A. Two alleles, fd35 and fd42, contained a
single nucleotide insertion and deletion, respectively, leading to
frameshifts within exon 5 of Y48A6C.3. All other sup-35 alleles
contained either large deletions or insertions within Y48A6C.3,
and are presumed to be null alleles (Figure 1A and data not
shown). Taken together, our findings strongly indicate that sup-35
Author Summary
One of the more puzzling aspects of genetics is that the
inactivation of many genes fails to produce strong
deleterious effects on the organisms that carry those
genes. In some cases, however, the combined inactivation
of two or more such genes can lead to the expression of
robust abnormal phenotypes. These types of synthetic
genetic interactions are thought to reflect the presence of
functional overlap or redundancy between the involved
genes. The root mechanisms that underlie synthetic
interactions are thought to be complex and are in most
cases poorly understood. Our work here focuses on one
case study where we have uncovered the molecular basis
underlying a complex set of genetic redundancies in C.
elegans. More specifically, we have discovered a novel
regulatory network that connects eight genes controlling
embryonic foregut development in the nematode C.
elegans. By solving mechanisms of this nature, our analysis
provides a means for understanding more generally the
principles that govern genetic redundancies. Our work also
provides insight into the bases of complex disease traits,
where the combined interactions of multiple genetic
factors leads to outcomes that determine health or
disease.
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these alleles were identified as spontaneous revertants ([31] and
this work), the sup-35 genomic region would appear to be
unusually unstable and subject to recombination events that lead
to gross alterations of the locus.
Based on the WormBase predicted gene model, as well as an
ORFeome-generated full-length cDNA, sup-35 encodes a 332-
amino-acid protein containing two N-terminal C2H2-type Zn-
finger domains along with two tetratrico peptide repeats (TPR) at
its C terminus. The molecular lesion identified in sup-35(e2223) is
predicted to disrupt the first Zn finger, indicating that this domain
is likely to be essential for SUP-35 function. The presence of the
Zn-finger motifs suggests a potential role for SUP-35 in
transcriptional regulation. Alternatively, the Zn-fingers may be
involved in protein-RNA, protein-protein, or protein-lipid inter-
actions.
Interestingly, other than its close paralog Y48A6C.1, SUP-35 is
most similar to an evolutionarily conserved family of RMD
(regulators of microtubule dynamics) proteins (Figure 1B; [32]. Of
the six RMD family members in C. elegans, SUP-35 is most similar
to RMD-2; the C-terminal 215 amino acids of SUP-35 are 52%
identical to a corresponding region in RMD-2, which in turn
shares greater homology with SUP-35 than with other C. elegans
RMD proteins (Figure 1B and data not shown). Interestingly,
RMD-2, along with RMD-1 and RMD-3, can physically associate
with microtubles in vitro [32]. Consistent with the RMD-like
domain of SUP-35 having an important functional role is the
observation that two alleles of sup-35, fd35 and fd42, may
specifically affect this region of the protein. Nevertheless, SUP-
35 differs from other C. elegans RMD family members, as well as
RMD proteins in other organisms, by the presence of its unique N-
terminal Zn-finger domains. The TPR domains in SUP-35 suggest
a possible role in protein-protein interactions [33].
SUP-35 shows a dynamic pattern of expression during
embryogenesis
To assess the pattern of SUP-35 expression during develop-
ment, multiple independent transgenic strains were generated
expressing full-length SUP-35 fused to GFP under the control of
the native sup-35 promoter/enhancer region (also see Materials
and Methods). For reasons described below, the SUP-35::GFP
expression analysis was performed in sup-36 and sup-37 mutant
backgrounds, both of which gave identical results.
SUP-35::GFP expression was first observed in embryos at
around the 50- to 100-cell stage. Expression of SUP-35::GFP was
ubiquitous throughout the proliferative phase of embryogenesis
and was strongly enriched in the cytoplasm (Figure 2A and 2B).
Commensurate with the onset of visible morphogenesis
(,400 minutes), SUP-35::GFP localization became pronounced
in nuclei, most notably in cells comprising the pharyngeal
primordium (Figure 2C and 2D). Pharyngeal cells also maintained
nuclear SUP-35::GFP expression throughout larval stages and into
adulthood (data not shown). In addition, weaker SUP-35::GFP
could be detected in the nuclei of several non-pharyngeal cells in
the posterior.
Mutations in sup-35 suppress synthetic pharyngeal
defects
Mutations in either sup-36 or sup-37 are capable of suppressing
all pair-wise combinations of mutations in lin-35, ubc-18, and pha-1
[29]. Consistent with this, the same constellation of synthetic-lethal
mutations was efficiently suppressed by loss of sup-35 (Table 1).
This includes suppression by the canonical allele of sup-35, e2223;
a consortium-generated deletion allele, tm1810; and by sup-
35(RNAi). Suppression by sup-35(tm1810) also further confirms
the molecular identity of this locus.
Previous studies from our laboratory have implicated the RING
finger–domain protein, ARI-1, as the primary co-partner of UBC-
18 in the regulation of pharyngeal development [34]. Consistent
with this, a consortium-generated deletion allele of ari-1, tm2549,
showed strong synthetic interactions with pha-1(ts), and this
lethality was suppressed by sup-35(RNAi) (Table 1). Taken
together, these findings suggest that sup-35 functions within a
regulatory network that includes pha-1, lin-35, ubc-18, and ari-1 to
control pharyngeal development.
sup-35 suppression of pha-1 mutations requires residual
PHA-1 activity
Extragenic suppression in C. elegans arises through a number of
distinct mechanisms [35]. Such mechanisms can, in some cases, be
distinguished based on whether or not suppression occurs in the
presence of a null allele. For this reason, we first sought to
determine whether the strongest characterized allele of pha-1,
e2123ts, retains activity at the non-permissive temperature of
25uC; e2123ts is a missense mutation that leads to a conversion of
cysteine to tyrosine at amino acid position 169 of PHA-1 [36]. We
thus generated high-copy extrachromosomal arrays carrying the
pha-1(ts) variant in mutant animals that were already chromo-
somally homozygous for the pha-1(ts) mutation. We then assayed
for the ability of pha-1(ts) high-copy overexpression to rescue the
lethal phenotype of pha-1(ts) mutants at 25uC. If the protein
product of pha-1(ts) were to retain residual activity at 25uC, we
Table 1. Suppression of multiple genotypes by sup-35.
Genotype Fertile adults (%)
pha-1(e2123ts)(16uC) 96.7 (n=365)
pha-1(e2123ts); lin-35(RNAi)(16uC) 2.4 (n=362)
sup-35(e2223) pha-1(e2123ts); lin-35(RNAi)(16uC) 98.3 (n=301)
lin-35; pha-1(e2123ts)(16uC) 0 (n=148)
lin-35; sup-35(e2223) pha-1(e2123ts)(16uC) 98.5 (n=289)
pha-1(e2123ts); ubc-18(RNAi)(16uC) 8.2 (n=261)
sup-35(e2223) pha-1(e2123ts); ubc-18(RNAi)(16uC) 97.6 (n=284)
pha-1(e2123ts); Y48A6C.1(RNAi)(25uC) 100 (n=353)
pha-1(e2123ts); Y48A6C.3(RNAi)(25uC) 100 (n=357)
lin-35; pha-1(fd1)
a 0 (n=248)
lin-35; pha-1(fd1); sup-35(RNAi) 54 (n=598)
lin-35; ubc-18
a 0 (n=137)
lin-35; ubc-18; sup-35(RNAi) 63 (n=180)
ari-1(tm2549); pha-1(e2123ts)(16uC)
b 1.5 (n=338)
ari-1(tm2549); pha-1(e2123ts); sup-35(RNAi)(16uC) 100 (n=465)
lin-35; pha-1(RNAi) 0 (n=394)
lin-35; sup-35(tm1810); pha-1(RNAi) 100 (n=381)
lin-35; sup-35(tm1810) ubc-18 100 (n=255)
All experiments performed at 20uC unless indicated. Experiments involving lin-
35 and ubc-18 were performed using the alleles n745 and ku354, respectively.
We note that pharyngeal morphology and function was normal in the
suppressed fertile adults.
aDouble mutants were derived from a parental strain carrying the lin-35-
rescuing extrachromosomal array, kuEx119.
bDouble mutants were maintained by propagating low-frequency escapers of
the synthetic lethality.
doi:10.1371/journal.pgen.1000510.t001
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sensitivity. As shown in Table 2, overexpression of pha-1(ts)
efficiently rescued defects associated with genomic pha-1(ts) loss of
function, indicating that, at 25uC, pha-1(e2123ts) does not behave
as a null allele.
Given the absence of a well-characterized null allele of pha-1,w e
decided to make use of a regional deficiency on chromosome III,
tDf2, which removes both the pha-1 and sup-35 loci, as well as 46–
72 additional genes (Figure 3A). Previous analysis, along with our
current work, indicates that homozygous tDf2/tDf2 mutants arrest
as embryos that display a phenotype closely resembling pha-1
strong loss-of-function mutations, suggesting that pha-1 may be the
earliest-acting zygotic gene within the region deleted by the
deficiency [31]. If so, then the apparent lack of suppression
observed in tDf2/tDf2 embryos, where both sup-35 and pha-1 are
deleted, would suggest that loss of sup-35 cannot suppress the pha-1
null phenotype. Alternatively, another early-acting gene within the
deficiency, one that is not suppressed by loss of sup-35, could be
responsible for the pha-1-like phenotype observed in tDf2/tDf2
homozygotes.
To distinguish between these two possibilities, we introduced an
extrachromosomal array containing wild-type copies of pha-1 into
a balanced strain that carries the tDf2 deficiency (tDf2/qC1 dpy-19
glp-1). In the absence of any array, this strain segregates ,25%
Figure 1. sup-35 genomic locus. (A) Genomic organization of sup-35 showing the locations of the two N-terminal C2H2-type Zn-finger domains
and the C-terminal RMD-like domain. sup-35 alleles that contain point mutations or single nucleotide insertions or deletions are indicated by bold
arrows. The large deletion alleles are represented by a gap in the gene structure; dotted lines indicate the approximate position of the deletion
breakpoints as determined by PCR. The consortium generated tm1810 deletion allele is indicated by the black bracket. tm1810 deletes 741
nucleotides and leads to translational termination following amino acid 62. (B) Peptide sequence alignment showing the similarity of SUP-35 to RMD-
2 and RMD-1. Consensus amino acids are indicated by white letters with black backgrounds, identical residues by white letters with dark-gray
backgrounds, and similar residues by black letters with light-gray backgrounds. Overall, SUP-35 is 37% identical to RMD-2 and 19% identical to RMD-
1. RMD-2 and RMD-1 are 30% identical.
doi:10.1371/journal.pgen.1000510.g001
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defects similar to those observed for pha-1(ts) mutants at 25uC
(Figure 3B). Strikingly, in the presence of pha-1 rescuing arrays, we
observed a substantial decrease in the frequency of embryonic
lethality (Figure 3B). This effect was observed using multiple
independently generated arrays, with the extent of embryonic
rescue corresponding closely to the transmission frequencies of the
individual arrays (Figure 3B and data not shown). Furthermore,
we observed a proportional increase in the percentage of array-
positive larval-lethal animals (Figure 3B), indicating that some
other gene within the deficiency is required for progression
through larval development. Taken together, these results
demonstrate that pha-1 is the earliest-acting zygotic gene within
tDf2 and, most importantly, that loss of sup-35 cannot suppress the
pha-1 null genotype. These findings are also consistent with the
observation that sup-35 pha-1(e2123)/tDf2 animals, which carry
only a single copy of the pha-1 hypomorphic allele, display much
weaker suppression than that of sup-35 pha-1(e2123) animals,
which retain two copies of this allele (data not shown; [31].
As an additional test, we made use of two recently generated
deletion alleles of pha-1 (tm3671 and tm3569; gift of National
Bioresource Project). tm3671 is a 203-bp deletion that removes
part of the second exon of pha-1, creating a premature stop codon
after 30 amino acids and is a presumed null allele. tm3569 contains
an in-frame 568-bp deletion extending from exon 2 through exon
4, which removes 149 amino acids of PHA-1 (isoform
Y48A6C.5a). Both pha-1(tm3671)/+ and pha-1(tm3569)/+ hetero-
zygous hermaphrodites produce ,25% embryonic-lethal F1
Figure 2. SUP-35::GFP expression. (A–D) DIC (A,C) and corresponding GFP (B,D) images of SUP-35::GFP (fdEx57) expression in embryos. The SUP-
35::GFP reporter encodes a full-length functional fusion protein that is expressed under the control of the native sup-35 promoter. Prior to overt
morphogenesis (A,B), SUP-35::GFP expression is predominantly cytoplasmic. After the initiation of body morphogenesis, SUP-35::GFP becomes
enriched in nuclei (C,D). The developing primordial pharynx is outlined by dashed lines in C and D. The embryos depicted are homozygous for a
mutation in sup-36(e2217) identical results were obtained using an independently generated array (fdEx58). Identical results were also obtained using
analogous arrays in the sup-37(e2215)background. Anterior is to the left. Scale bar in A, 10 mm for A–D.
doi:10.1371/journal.pgen.1000510.g002
Table 2. pha-1(e2123ts) retains partial activity at non-permissive temperatures.
Genotype Total Embryos % Embryonic lethality at 25uC
a % Larval lethality at 25uC
a
pha-1(e2123ts) 384 94.2 5.7
pha-1(e2123ts); fdEx51 128 (GFP+)0 0
199 (GFP2)9 4 . 9 5 . 0
pha-1(e2123ts); fdEx53 141 (GFP+)0 0
255 (GFP2)9 4 . 5 5 . 4
The independently derived extrachromosomal arrays fdEx51 and fdEx53 carry multiple copies of the pha-1(e2123ts) allele in addition to the sur-5::GFP marker.
aBoth embryonic- and larval-lethal animals exhibited the Pun phenotype.
doi:10.1371/journal.pgen.1000510.t002
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with our deficiency analysis, growth of pha-1(tm3671)/+ and pha-
1(tm3569)/+ heterozygotes on sup-35(RNAi) failed to decrease the
percentage of embryonic-arrested progeny, further indicating that
reduction of sup-35 activity cannot suppress complete loss of
function of pha-1 (data not shown). In contrast, sup-35(RNAi)
efficiently suppressed the lethality of pha-1(ts) mutants (at 25uC), as
well as all tested synthetic phenotypes (Table 1).
SUP-35 is a transcriptional repressor of pha-1
Given that loss of sup-35 cannot suppress the pha-1 null
genotype, we hypothesized that SUP-35 may function as a
negative upstream regulator of pha-1. Furthermore, because SUP-
35 contains C2H2-type Zn fingers that are critical for its activity
(Figure 1A), we reasoned that SUP-35 may mediate repression of
pha-1 at the level of transcription (Figure 4A). Consistent with this,
qRT-PCR experiments revealed embryonic pha-1 mRNA levels to
be 2- to 4-fold more abundant in sup-35(tm1810) mutants as
compared with wild type using two independent internal
normalization controls (Figure 4B). An even greater increase in
pha-1 mRNA levels was observed in embryos from sup-35(e2223)
pha-1(ts) double mutants relative to pha-1(ts) single mutants
(Figure 4C). This latter result is significant in that pha-1 mRNA
levels were assessed in a genetic background in which PHA-1
activity is compromised. The observed difference in the degree to
which pha-1 is upregulated in these strains could reflect a
heightened sensitivity to SUP-35 levels in the pha-1 mutant
background or could be due to differences between the two sup-35
alleles used in these studies.
As a secondtest,we made useof a previously described strainthat
expresses a functional full-length PHA-1::GFP fusion protein [29].
Because this fusion protein is regulated by sequences derived from
the native pha-1 promoter, its expression should be sensitive to
alterations in the activities of endogenous transcriptional regulators.
Consistent with data obtained from qRT-PCR, PHA-1::GFP was
upregulated at least 2-fold in sup-35(tm1810) mutants relative to
wild-type embryos(Figure4Dand4F–4I;FigureS1).These findings
also indicate that changes in pha-1 mRNA levels lead to
corresponding changes in the abundance of PHA-1 protein.
The above results indicate that SUP-35 may negatively regulate
pha-1 at the level of transcription or mRNA stability. To
distinguish between these possibilities, we assayed expression levels
of a Ppha-1::GFP reporter [29] in wild-type and sup-35 mutants.
Because this construct contains only the 59 upstream regulatory
region of pha-1, effects on mRNA stability through the pha-1
39UTR should not be observed. Using this reporter, we observed
that Ppha-1::GFP is upregulated ,3-fold in sup-35 mutants versus
wild-type embryos (Figure 4E; Figure S1). Taken together, these
Figure 3. Analysis of a chromosomal deficiency that removes both sup-35 and pha-1. (A) Genetic map showing extent of the tDf2 deficiency.
Although theprecise molecular endpointsareunknown, tDf2 minimallyextends from vab-7 to spe-16 but does not encompass dpy-28 anddpy-18. Based
on an analysis of genes within the region, tDf2 leads to the deletion of 48 to 74 genes, including sup-35 and pha-1. (B) Percentage of embryonic- and
larval-lethal F1 animals observed for each of the indicated parental genotypes. tDf2/qC1 dpy-19 glp-1 is a balanced strain that segregates 25% tDf2/tDf2
homozygous progeny.fdEx77andfdEx75areindependentlygeneratedextrachromosomalarraysthatexpress wild-typepha-1andthe sur-5::GFPmarker.
Note that strains carrying the pha-1-rescuing arrays display a pronounced reduction in the frequency of embryonic lethality along with a concomitant
increase in larval lethality. Furthermore, the decrease in embryonic lethality is proportional to the transmission frequencies of the individual arrays;
fdEx77 and fdEx75 exhibit transmission frequencies of 50% (n=140) and 39% (n=182), respectively. In addition, for parental strains harboring either the
fdEx77 or fdEx75 arrays, .80% of the observed larval-lethal F1 progeny expressed GFP. Emb, embryos; Lvl, L1 larvae.
doi:10.1371/journal.pgen.1000510.g003
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PLoS Genetics | www.plosgenetics.org 6 June 2009 | Volume 5 | Issue 6 | e1000510Figure 4. SUP-35 negatively regulates pha-1. (A) Testable model for the regulation of PHA-1 by SUP-35. (B,C) Quantification of endogenous pha-
1 mRNA levels in embryos by qRT-PCR in sup-35(tm1810) single mutants (B) or sup-35(e2223) pha-1(e2123 double mutants (C) using act-1 (black bar)
and ama-1 (gray bar) as loading controls. Fold changes were obtained after normalizing to wild type (B) or pha-1(e2123) single mutants (C). Error bars
represent s.e.m. Means of the indicated groups were analyzed for significance using a two-tailed Student’s t-test (*p,0.0). Quantification of PHA-
1::GFP (D) and Ppha-1::GFP (E) fluorescence in wild-type and sup-35(tm1810)mutants. The average mean GFP intensity for each genotype was analyzed
for significance using a two-tailed Student’s t-test (*p,0.0001). (F–I) Representative GFP (F,H) and corresponding DIC (G,I) images of PHA-1::GFP
expression in wild type (F,G) and sup-35(tm1810)mutants (H,I). Digital camera exposure times were identical for all embryos assayed. Mean GFP
intensities were determined as described in Materials and Methods. Scale bar in F, 10 mm for F–I.
doi:10.1371/journal.pgen.1000510.g004
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inhibit pha-1 at the level of transcription.
SUP-35 acts genetically upstream of sup-36 and sup-37 to
inhibit pha-1
If SUP-35 negatively regulates pha-1,t h e nsup-35 overexpression
should cause a reduction in PHA-1 levels and therefore would be
expected to phenocopy pha-1 loss-of-function mutations. Consistent
with this, extensive attempts to revert the suppression of sup-35; pha-1
mutants through the expression of wild-type sup-35 via an
extrachromosomal array failed to generate stable transgenic lines.
This includes experiments in which sup-35 was engineered to be
present at low copy numbers. In addition, sup-35 transgenic
expression was also highly toxic to wild-type animals, as was
expression of the SUP-35::GFP fusion protein. Given that SUP-35
may require the pha-1 suppressors SUP-36 and SUP-37 to mediate its
activities, we hypothesized that SUP-35 overexpression may not be
toxic in genetic backgrounds that remove either sup-36 or sup-37
activities. Consistent with this prediction, we encountered no
difficulties in obtaining stable transgenic lines carrying wild-type
sup-35 ( o rS U P - 3 5 : : G F P )a th i g hc o p yn u m b e ri ne i t h e rt h esup-36 or
sup-37 mutant background (also see Materials and Methods). This
finding indicates that SUP-36 and SUP-37 function genetically
downstream of SUP-35. However, SUP-36 and SUP-37 could
conceivably function upstream of SUP-35 if they are required for
SUP-35 activation.
To determine directly the phenotypic effects of SUP-35
overexpression in a wild-type background, we performed a series
of genetic crosses, an example of which is shown in Figure 5A. sup-
35 overexpression was toxic to hermaphrodites that expressed
both sup-36 and sup-37 zygotically, even if sup-36 or sup-37 were
absent maternally. Surprisingly, sup-35 overexpression was not
toxic in males that expressed both sup-36 and sup-37 zygotically,
provided that either sup-36 or sup-37 maternal contributions were
absent. In contrast, sup-35 overexpression was toxic to both males
and hermaphrodites when both sup-36 and sup-37 were present
maternally and zygotically. Most strikingly, non-viable sup-35-
overexpressing embryos and larvae obtained through these crosses
had a phenotype that was identical to strong pha-1 loss-of-function
mutations (Figure 5B and 5C). Taken together, these results are
consistent with our finding that SUP-35 functions as a negative
regulator of pha-1 and further indicate that SUP-35 acts together
with SUP-36 and SUP-37 to control pha-1 expression levels.
SUP-35 acts through pha-1 to suppress synthetic
pharyngeal defects
Our above analyses strongly indicate that sup-35 suppression of
partial loss-of-function mutations in pha-1 occurs through the
upregulation of pha-1 mRNA, which in turn leads to increased
PHA-1 protein levels (Figure 4). An extension of this model is that
suppression of the synthetic pharyngeal genotypes by sup-35
(Table 1) may occur through an identical mechanism. If that is the
case, then an increase in PHA-1 levels, even in the presence of
wild-type sup-35, should be sufficient to suppress the synthetic
phenotype of lin-35; ubc-18 double mutants. To address this, we
overexpressed wild-type PHA-1 from high-copy extrachromosom-
al arrays in lin-35; ubc-18 double mutants and assayed for rescue.
Strong suppression of synthetic lethality was observed in three out
of three independent transgenic lines, leading to the generation of
viable double mutant strains that carried only the PHA-1-
overexpression transgenic array. This finding is consistent with
the hypothesis that sup-35-mediated suppression of pha-1(ts) and
the synthetic genotypes occurs through the same mechanism.
A second prediction of the above model is that inhibition of pha-
1 activity should revert the suppression observed in lin-35; sup-
35(tm1810) ubc-18 triple mutants (Table 1). We therefore subjected
triple mutants to pha-1(RNAi) feeding and assayed for loss of
suppression. Whereas 100% (n=255) of lin-35; sup-35 ubc-18
animals reached adulthood when grown on vector-RNAi control
plates, only 12.9% (n=200) of triple mutants grown on pha-
1(RNAi) escaped embryonic or early-larval arrest. This finding
further supports the model that sup-35-mediated suppression of
both strong loss-of-function pha-1 mutants and the synthetic
genotypes occurs through the common mechanism of increasing
PHA-1 levels.
LIN-35, UBC-18–ARI-1, and HCF-1 function upstream of
SUP-35 to regulate PHA-1 expression
In considering potential regulatory networks that could account
for both the molecular and genetic data described above, we were
able to construct a relatively straightforward model. In this
scenario, LIN-35, functioning as a transcriptional repressor
(Figure 6A), and UBC-18–ARI-1, acting as a complex to promote
target protein degradation (Figure 7A), are negative regulators of
SUP-35. Thus in lin-35; ubc-18 double mutants, increased levels of
SUP-35 would lead to the inhibition of PHA-1 and associated
defects in pharyngeal development.
We first tested this model by examining the role of LIN-35 in
the expression of endogenous sup-35. Consistent with the model,
embryonic levels of sup-35 mRNA are increased ,4-fold in lin-35
mutants as compared with wild type (Figure 6B). Correspondingly,
SUP-35::GFP was upregulated 2- to 3-fold in embryos following
lin-35(RNAi) treatment (Figure 6C; Figure S2), indicating that
changes in sup-35 mRNA levels are further reflected by changes in
the abundance of SUP-35 protein. Most importantly, we observed
an ,5- to 10-fold reduction in the levels of endogenous pha-1
mRNA in embryos derived from lin-35 mutants versus those from
wild type (Figure 6B). This latter result also provides an
explanation for why mutations in lin-35 are strongly synthetic
with hypomorphic mutations in pha-1 (also see Discussion).
We next examined the roles of UBC-18 and ARI-1 in the
regulation of SUP-35 and PHA-1. In contrast to findings from lin-
35 mutants, embryonic sup-35 mRNA levels in ubc-18 mutants
were identical to those observed in wild type (Figure 7B).
Nonetheless, embryonic SUP-35::GFP protein levels were sub-
stantially increased following RNAi inhibition of ubc-18 or ari-1
(Figure 7C; Figure S2). These results indicate that UBC-18–ARI-1
negatively regulates SUP-35 post-transcriptionally, possibly at the
level of SUP-35 stability. Consistent with this, we find that SUP-
35::GFP is a target for ubiquitination in cell extracts from whole
worms (Figure 7D). Furthermore, we observed that the increase in
SUP-35 levels in ubc-18 mutants correlates with a decrease in the
expression levels of pha-1 mRNA (Figure 7B). These findings, in
combination with other molecular and genetic data, strongly
support the model that LIN-35 and UBC-18–ARI-1 promote pha-
1 transcription by inhibiting SUP-35 expression and stability.
In previous studies, we have implicated the C. elegans E2F
ortholog, EFL-1, as a regulatory partner of LIN-35 in the control
of pharyngeal development [29], and have also defined the C.
elegans E2F consensus binding motif [13]. Consistent with a role for
E2F in the regulation of sup-35, we identified three candidate E2F
bindings sites within the first 700 bp of the sup-35 promoter region.
One of these sites, located approximately 230 bp upstream of the
predicted transcriptional start site (GATTCGCGCCT), con-
formed to all published criteria, suggesting that E2F may
potentially regulate sup-35 directly.
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as an important physical and functional co-partner of E2F in the
activation of E2F target genes [37,38]. For example, loss of HCF-1
activity in hamster cells leads to a reduction in the expression of
E2F-regulated genes required for G1 entry resulting in arrest in G0
[39]. Interestingly, this G0 arrest can be bypassed through the
inhibition of pRb family members, indicating that mammalian
HCF-1 and pRb carry out opposing functions on E2F targets [40].
The presence of a structurally and functionally conserved ortholog
of HCF-1 in C. elegans [41–43], led us to hypothesize that a similar
regulatory relationship may exist in C. elegans (Figure 8A). To test
this, we assayed levels of sup-35 mRNA in lin-35 mutants subjected
to hcf-1(RNAi) by qRT-PCR. Notably, we observed an ,2-fold
reduction in the levels of sup-35 mRNA in lin-35; hcf-1(RNAi)
embryos as compared with lin-35 mutants treated with a control
RNAi (Figure 8B).
To see if the observed reduction in sup-35 mRNA levels by hcf-
1(RNAi) has a functional consequence in lin-35; ubc-18 and lin-35;
pha-1 double mutants, we carried out hcf-1(RNAi) in these
backgrounds and assayed for suppression of larval arrest, leading
to the generation of fertile adults. Notably, reduction of hcf-1
activity led to pronounced suppression of arrest in both lin-35; ubc-
18 and lin-35; pha-1 mutant backgrounds (Figure 8C). We note
that the partial phenotypic suppression of the synthetic mutants by
hcf-1(RNAi) is consistent with the incomplete correction of sup-35
overexpression in lin-35; hcf-1(RNAi) embryos (Figure 8B). In
addition, hcf-1(RNAi) resulted in suppression of pha-1(ts) mutants at
the intermediate temperature of 20uC, leading to a marked
Figure 5. SUP-35 overexpression phenocopies pha-1 loss of function. (A) Representative genetic strategy applied to assay the effects of SUP-
35 overexpression in wild type and in sup-36 and sup-37 mutant backgrounds. Wild-type males carrying an integrated myo-2::GFP reporter (mIs11)
were crossed into pha-1; sup-36 hermaphrodites carrying a sup-35-overexpressing extrachromosomal array (fdEx59). Although this mating failed to
produce viable F1 cross-progeny hermaphrodites, fertile cross-progeny males were generated, which were identified by expression of the myo-2::GFP
reporter. F1 cross-progeny males were then mated to wild-type or sup-36 hermaphrodites, and cross-progeny were identified based on the myo-
2::GFP reporter. Mating into the N2 strain failed to produce viable cross-progeny males or hermaphrodites, whereas mating to sup-36 generated both
viable and non-viable male and hermaphrodite F2 cross-progeny. Non-viable F2 cross-progeny from both matings displayed a Pun (Pharynx
unattached) phenotype, and these animals uniformly carried the fdEx59 array. Identical results were also obtained for sup-37 mutants using the above
strategy, and similar findings were obtained for both sup-36 and sup-37 using additional genetic approaches (see Materials and Methods). (B,C) DIC
images of a typical non-viable embryo (B) and larva (C) obtained through the above mating. Note the Pun phenotype. Black and white arrowheads
indicate the anterior and posterior pharyngeal boundaries, respectively. Scale bar in C, 1 mm for B,C.
doi:10.1371/journal.pgen.1000510.g005
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increase in the frequency of fertile adults (Figure 8C).
Discussion
Identification and characterization of SUP-35
We report here the molecular identification and analysis of
SUP-35. We provide evidence that loss of sup-35 activity
specifically suppresses the embryonic- and larval-lethal phenotypes
of pha-1 hypomorphic alleles. Additionally, loss of sup-35 activity
efficiently suppressed the synthetic lethal phenotypes of lin-35; pha-
1 and lin-35; ubc-18 double mutants, as well as a number of related
genotypes. sup-35 is predicted to encode a C2H2-type Zn-finger
protein, consistent with a role in transcriptional regulation
(Figure 1), although other functional activities associated with Zn
fingers domains are possible. Based on sequence similarity, SUP-
35 is also a new member of the RMD family of proteins, several of
which have been shown to associate with microtubules [32].
During early embryonic development, a functional SUP-35::GFP
protein was expressed predominantly in the cytoplasm of most or
all cells. Notably, at the onset of morphogenesis, SUP-35::GFP
expression became enriched in pharyngeal nuclei (Figure 2). How
this dynamic pattern of expression, as well as a potential
association with microtubules, may contribute to the functions
and regulation of SUP-35 is currently unclear. Further studies of
SUP-35, as well as the additional suppressors SUP-36 and SUP-
37, should shed light on these facets of SUP-35 regulation.
A model for the redundant regulation of PHA-1
In previous work, we have shown that LIN-35, a transcriptional
repressor, and UBC-18–ARI-1, an E2-E3 ubiquitin ligase
complex, redundantly regulate pharyngeal morphogenesis
[21,34]. In addition, mutations in lin-35, ubc-18, and ari-1 strongly
enhance the pharyngeal morphogenetic defects of partial loss-of-
function mutations in pha-1 [29,34]. In our current study, we
provide both molecular and genetic evidence that LIN-35 and
UBC-18–ARI-1 function as negative regulators of SUP-35, which
in turn functions as a transcriptional repressor of pha-1. Thus, in
our model, both LIN-35 and UBC-18–ARI-1 are positive, albeit
indirect, regulators of PHA-1 through the inhibition of SUP-35
(Figure 9).
Evidence to support this model includes the findings that pha-1
overexpression efficiently rescued the synthetic lethality of lin-35;
ubc-18 double mutants and that the suppression observed in lin-35;
ubc-18 sup-35 triple mutants was reversed by pha-1(RNAi).
Furthermore, sup-35 overexpression in a wild-type background
phenocopied pha-1 loss of function (Figure 5). Consistent with the
genetic data, qRT-PCR and GFP reporters indicate that sup-35
mRNA and protein levels were upregulated in embryos where lin-
35 activity had been compromised, whereas ubc-18 and ari-1
specifically affected SUP-35 protein levels (Figure 6). Additionally,
endogenous pha-1 mRNA levels were decreased in lin-35 and ubc-
18 mutants, whereas pha-1 mRNA and protein levels were
increased in sup-35 mutants (Figure 6, Figure 7). This model
accounts for both the synthetic lethality of lin-35; ubc-18 double
mutants as well as the genetic interactions observed between pha-1
and lin-35, ubc-18, and ari-1,a spha-1 hypomorphic mutations
would be expected to be hypersensitive to conditions that further
reduce pha-1 mRNA levels.
An additional prediction of this model is that strong loss-of-
function pha-1 mutants should minimally phenocopy the defects
observed in lin-35; ubc-18 and lin-35; pha-1 mutants. Specifically,
lin-35; ubc-18 and lin-35; pha-1 mutants show early-stage defects in
the re-orientation of anterior epithelial cells within the pharyngeal
primordium [21,29]. Surprisingly, however, we had previously
failed to observe re-orientation defects in pha-1(ts) embryos grown
at 25uC [29], even though these mutants show severe pharyngeal
morphogenesis defects at later stages [29,30]. We have subse-
quently repeated these experiments and, consistent with our earlier
study, find little or no evidence for early-stage morphogenesis
defects in pha-1(ts) embryos grown at the non-permissive
temperature on either NGM or vector-RNAi control plates (data
Figure 6. Regulation of sup-35 and pha-1 by LIN-35. (A) Testable model for the regulation of SUP-35 and PHA-1 by LIN-35. (B) Quantification of
endogenous sup-35 and pha-1 mRNA levels in embryos by qRT-PCR in lin-35 mutants using act-1 as an internal normalization control. Fold changes
were obtained after normalizing to N2. Note that consistent with sup-35 mRNA upregulation in lin-35 mutants, pha-1 mRNA is significantly
downregulated. (C) Quantification of SUP-35::GFP protein levels in embryos following RNAi inhibition of lin-35 (also see Figure S1). Animals assayed
were of genotype pha-1(e2123); sup-36(e2217); fdEx57 (SUP-35::GFP) embryos of the genotype pha-1(e2123); sup-37(e2215); fdEx63 (SUP-35::GFP
showed similar trends (data not shown). Error bars represent s.e.m. The means of the indicated groups were analyzed for significance using a two-
tailed Student’s t-test. *p,0.05 and **p,0.0001.
doi:10.1371/journal.pgen.1000510.g006
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1(RNAi) plates did display early-stage pharyngeal morphogenesis
defects, demonstrating that a specific reduction in pha-1 activity
can phenocopy the early-stage defects observed in the synthetic
mutants (data not shown). Moreover, the frequency and severity of
pha-1(ts); pha-1(RNAi) morphogenesis defects were similar to those
observed for pha-1(ts); lin-35(RNAi) and pha-1(ts); ubc-18(RNAi)
embryos grown at 16uC (data not shown). These observations
indicate that early-stage defects in pha-1(ts) mutants are suppressed
by growth at 25uC, suggesting an effect of temperature on the
underlying process of cell re-orientation. Most importantly, these
findings are internally consistent with our model, in which PHA-1
levels are positively regulated by LIN-35 and UBC-18 through the
inhibition of SUP-35 (Figure 9).
Our observation that mutations in sup-36 and sup-37 abolish
SUP-35-mediated toxicity indicate that sup-36 and sup-37 act
genetically downstream of SUP-35. Thus, SUP-36 and SUP-37
may potentially function downstream of SUP-35 in a linear
pathway to control pha-1 expression. Alternatively, SUP-36 and
SUP-37 may act in a complex with SUP-35, or in a parallel
pathway that is required for SUP-35 activation (Figure 9).
We also find that inhibition of hcf-1 by RNAi leads to a partial,
though significant, suppression of larval arrest in lin-35; ubc-18 and
lin-35; pha-1 mutants as well as the substantive suppression of both
the L1 arrest and Pun (Pharynx unattached) phenotypes of pha-
1(ts) mutants at 20uC. This genetic suppression correlates well with
the observed decrease in sup-35 mRNA levels in lin-35; hcf-1(RNAi)
embryos. These results are consistent with our current model as
Figure 7. Regulation of sup-35 and pha-1 by UBC-18–ARI-1. (A) Testable model for the regulation of SUP-35 and PHA-1 by UBC-18–ARI-1. (B)
Quantification of sup-35 and pha-1 endogenous mRNA levels in embryos by qRT-PCR in ubc-18(ku354 mutants using act-1 as an internal normalization
control. Fold changes were obtained after normalizing to N2. Note that although pha-1 mRNA was significantly decreased in ubc-18 mutants, sup-35
mRNA levels were unaffected. (C) Quantification of SUP-35::GFP protein levels in embryos following RNAi inhibition of ubc-18 and ari-1 (also see
Figure S1). Note that SUP-35::GFP protein levels were substantially increased following inhibition of ubc-18 and ari-1. Animals assayed were of
genotype pha-1(e2123); sup-36(e2217); fdEx57 (SUP-35::GFP) embryos of the genotype pha-1(e2123); sup-37(e2215); fdEx63 (SUP-35::GFP showed similar
trends (data not shown). Error bars (B and C) represent s.e.m. The means of the indicated groups were analyzed for significance using a two-tailed
Student’s t-test (*p,0.05 and **p,0.000). (D) SUP-35::GFP was immunoprecipitated from whole worm lysates of strain WY518 using polyclonal anti-
GFP antibodies. The immunoprecipitates were analyzed by western blot using monoclonal antibodies to either GFP or ubiquitin. Lysates from Jurkat
cells grown in the presence of the proteosomal inhibitor LLnL were used as a positive control for ubiquitinated products and as a negative control for
GFP. The expected size of the non-ubiquitinated SUP-35::GFP fusion protein is ,68 kDa.
doi:10.1371/journal.pgen.1000510.g007
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[29,44], and append our model with the addition of a
phylogenetically-conserved component of the E2F network
(Figure 9). Our finding also indicates that additional novel
suppressors may be identified through the use of sensitized strains.
Elucidating the mechanistic bases of synthetic genetic interac-
tions will continue to be a major challenge for the field of
developmental genetics. These types of interactions will also likely
be critical to our understanding of complex disease traits in
humans. For example, a recent commentary in the New England
Journal of Medicine states that ‘‘many, rather than few, variant
risk alleles are responsible for the majority of the inherited risk of
each common disease’’ [45].
Our current analysis provides a straightforward model to
account for the genetic redundancies observed in an additional
case study. Although understanding different sets of genetic
Figure 8. Regulation of sup-35 by HCF-1. (A) Testable model for the regulation of sup-35 by hcf-1. (B) Quantification of endogenous sup-35 mRNA
levels by qRT-PCR in lin-35 and lin-35; hcf-1(RNAi) embryos using act-1 as an internal normalization control. Note that sup-35 mRNA levels drop ,2
fold in hcf-1(RNAi)-treated lin-35 mutants as compared with vector RNAi-treated lin-35 single mutants. Fold changes were obtained after normalizing
to N2. Error bars represent s.e.m and significance was calculated using a two-tailed Student’s t-test (*p,0.05). (C) Suppression of larval arrest in pha-
1(ts) and synthetic mutants by hcf-1(RNAi). hcf-1(RNAi) effectively increases the frequency of fertile adults by suppressing the larval lethality of lin-
35;pha-1 and lin-35;ubc-18 double mutants. Similar results were also observed for pha-1(ts) at the intermediate temperature of 20uC, but not at 25uC.
(D) hcf-1(RNAi) strongly suppresses the Pun (Pharynx unattached) in pha-1(ts) mutants at 20uC, but not 25uC. These results were also duplicated using
RNAi injection to target a different region of the hcf-1 transcript (Materials and Methods and data not shown).
doi:10.1371/journal.pgen.1000510.g008
Mechanism of Coordinated Pharyngeal Development
PLoS Genetics | www.plosgenetics.org 12 June 2009 | Volume 5 | Issue 6 | e1000510interactions will undoubtedly require unique solutions, we contend
that certain patterns of redundancy are likely to emerge. In this
case, we have shown that a redundancy between a transcriptional
regulator, LIN-35, and a mediator of protein stability, UBC-18–
ARI-1 can be explained through the negative regulation of a
common target, SUP-35. Similarly, we have previously shown that
LIN-35 and FZR-1, a substrate-specificity component of the APC
(anaphase-promoting complex) E3 ligase, mutually inhibit the
expression levels of G1 cyclins [14]. Thus, a potential theme to
emerge from our studies is the redundant control of common
targets through distinct mechanisms of negative regulation.
Additional studies into synthetic phenotypes in C. elegans and
other systems should further elucidate general themes that may
govern genetic redundancy.
Materials and Methods
Strains and maintenance
C. elegans were maintained using standard procedures [46].
Strains used in our analysis include GE24 [pha-1(e2123)], GE348
[dpy-18 sup-35(e2223) pha-1(e2123)], WY83 [lin-35; ubc-18;
kuEx119(lin-35+; sur-5::GFP], WY119 [lin-35; pha-1(fd1); kuEx119],
sup-35(tm1810), WY477 [dpy-18 pha-1(e2123); ari-1(tm2549)],
WY482 [sup-35(tm1810); SM469 (PHA-1::GFP; pRF4 rol-6gf)],
WY527–528, [lin-35;ubc-18; kuEx119; fdEx72–73 (pBX;rol-
6(su1006gf))], WY529–530 [lin-35; ubc-18; fdEx72–73] GE2158
[tDf2/qC1 dpy-19(e1259) glp-1(q339)], WY539–542 [unc-13 lin-35;
dpy-17 ubc-18 sup-35(tm1810)], GE348 [dpy-18 sup-35(e2223) pha-
1(e2123ts)], GE551 [vab-7(e1562) sup-35(t1013) pha-1(e2123ts)],
GE552 [vab-7(e1562) sup-35(t1014) pha-1(e2123ts)], GE913 [vab-
7(e1562) sup-35(t1016) pha-1(e2123ts)], GE914 [vab-7(e1562) sup-
35(t1015) pha-1(e2123ts)], GE915 [vab-7(e1562) sup-35(t1017) pha-
1(e2123ts)], and WY453–466 [sup-35 (fd33–46) pha-1(e2123ts)].
SM35 [PHA-1::GFP], SM36 [Ppha-1::GFP].
To analyze SUP-35 overexpression and toxicity, the following
strains were generated using either a sup-35 genomic fragment or a
cloned sup-35:GFP construct: WY512–513 [pha-1(e2123ts); sup-
36(e2217); fdEx57–58 (sup-35::GFP; rol-6)], WY514–517 [pha-
1(e2123ts); sup-36(e2217); fdEx59–62 (sup-35 genomic fragment; sur-
5::GFP)], WY518 [pha-1(e2123ts); sup-37(e2215); fdEx63 (sup-
35::GFP; rol-6)], WY519–520 [pha-1(e2123ts); sup-37(e2215);
fdEx64–65(sup-35 genomic fragment; sur-5::GFP)], WY523–524 [dpy-
Figure 9. Model for the regulation of PHA-1. Schematic of the regulatory circuit acting upstream of PHA-1. We note that regulation of SUP-35
by LIN-35, HCF-1, and UBC-18–ARI-1 may not be direct, but could involve intermediate steps. For additional details, see text.
doi:10.1371/journal.pgen.1000510.g009
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526, [dpy-11 sup-3; fdEx70–71 (sup-35::GFP; rol-6)].
Strains used for rescue analysis of pha-1(e2123ts) and the
chromosomal deficiency tdf2 included WY506–511 [pha-
1(e2123ts); fdEx51–56(pBX/e2123; sur-5::GFP)] and WY531–534
[tDf2/qC1 dpy-19(e1259) glp-1(q339); fdEx74–77(pBX; sur-5::GFP)].
lin-35(n745; ubc-18(ku354 sup-35(tm1810) triple mutants were
generated by crossing sup-35(tm1810)/+ males to dpy-17 ubc-18 unc-
32 hermaphrodites. Cross-progeny were allowed to self, and the
resulting Dpy non-Unc recombinants were assayed for the sup-
35(tm1810) deletion by PCR. Confirmed dpy-17 ubc-18 sup-
35(tm1810) triple-mutant hermaphrodites were then crossed to
unc-13 lin-35/+ males. Following selfing of the cross-progeny, Dpy
Unc animals were confirmed for lin-35(n745), ubc-18 (ku354), and
sup-35(tm1810) by PCR and DNA sequencing.
To test for rescue of lin-35; ubc-18 double mutants by pha-1
overexpression, plasmid pBX, which contains a rescuing segment
of the pha-1 genomic locus [47], was co-injected with pRF4, which
contains the dominant rol-6(su1106) marker [48], into strain
WY83. Stable double transgenics were recognized by the presence
of rolling sur-5::GFP(+) animals. Rescue was then determined by
the presence of rolling viable non-GFP adults that could be further
propagated in the absence of kuEx119.
Construction of plasmids
A SUP-35::GFP fusion (pDF101)was constructed as follows. An
,2.5-kb sup-35 genomic fragment, which includes the upstream sup-
35 promoter/enhancer region, was amplified using the primer pair
59-GCTCTAGATGATAGTCGTGTCGGTGGTCGTC-39 and
59-CGCGGATCCAATTGAGCACAAGTCAAGGGCGTCG-39.
This fragment was digested with BamHI and XbaI and cloned in-
frame into a similarly restricted pPD95.77 vector (gift of A. Fire). All
recombinant clones were verified by restriction digestion and
sequencing.
For the rescue of pha-1(e2123ts) mutants by pha-1(e2123ts)
overexpression, a fragment of the pha-1 genomic locus was
amplified from pha-1(e2123ts) mutants using the primer pair 59-
CAGGACAATGATCTCGCCTT-39 and 59-TATCTTTTCA-
CATGGAATACATGTAG39 and digested with SalI and BsaBI.
This fragment was then used to replace the analogous region of
pBX. Recombinant plasmids carrying the e2123ts mutation were
identified by digestion with Bst1107I, which recognizes the SNP
created by the e2123ts point mutation, and further confirmed by
sequencing.
RNAi
RNAi feeding was carried out using standard protocols, and
plates were cultured at 25uC to score for suppression [49]. The
RNAi constructs JA:Y48A6C.3, JA:Y48A6C.5, and JA:R01H12.6
were used to target sup-35, pha-1, and ubc-18 gene products,
respectively. RNAi constructs used to target lin-35 and ari-1 were
previously described [14,34]. hcf-1(RNAi) feeding was carried out
using construct JA:C46A5.9, corresponding to exons 2–4. RNAi
injection of hcf-1 was carried out by gonadal injection of dsRNA
(,1.0 mg/ml) corresponding to exons 5 and 6.
Fluorescence microscopy and measurements
Fluorescence microscopy was performed using a Nikon Eclipse
microscope. Quantification of the GFP fluorescence in embryos
was carried out using Open Lab Software Version 5.0.2. All
images were captured using identical exposure times, and all
embryos used in our analysis were of similar developmental stages
(,200–300 cells). An average of the mean fluorescence was
calculated to compare GFP expression levels. P values were
determined using a Student’s t-test.
SUP-35 overexpression and toxicity
Because multicopy transgene expression of SUP-35 and SUP-
35::GFP was toxic in wild-type backgrounds, arrays were initially
generated in sup-36 and sup-37 mutants. To determine the effect of
SUP-35 and SUP-35::GFP overexpression in wild-type animals,
males of genotype +/+; mIs11 (myo-2::GFP) were crossed to pha-
1(e2123ts); sup-36; fdEx59 hermaphrodites. fdEx59 expresses wild-
type sup-35 and the co-injection marker sur-5::GFP. Such crosses
resulted in the generation of fdEx59+ F1 males only, which were
identified by the presence of both sur-5::GFP and myo-2::GFP.F 1
males were then mated to either N2 hermaphrodites or
homozygous sup-36 hermaphrodites. When the F1 males were
crossed to sup-36 hermaphrodites, non-viable Pun and viable
cross-progeny animals were obtained, whereas all the cross-
progeny from the N2 hermaphrodite matings were non-viable and
exhibited the Pun phenotype. These results were reproduced using
three independently generated extrachromosomal arrays in both
sup-36 and sup-37 mutant backgrounds. Similar results were also
obtained for the SUP-35::GFP construct co-injected with pRF4.
As an alternative approach, males of the genotype dyp-13 unc-
24/+ were crossed to pha-1(e2123ts); sup-36; fdEx59 hermaphro-
dites. F1 hermaphrodites were placed on individual plates and
allowed to self; cross-progeny were determined by the presence of
Dpy Unc animals. In the event that SUP-35 overexpression was
non-toxic, half of the cross-progeny F1s [pha-1(e2123ts)/+;sup-36/
dpy-13 unc-24; fdEx59] should have segregated one-sixteenth of the
F2 animals with a genotype of +/+; dpy-13 unc-24; fdEx59.
Although our crosses resulted in a high frequency of F1 cross-
progeny males, they failed to produce F1 hermaphrodites that
segregated Dpy Unc F2 animals. To extend these results, F1 cross-
progeny males were subsequently crossed to N2 hermaphrodites.
This cross resulted in fdEx59+ animals that arrested uniformly as
arrested embryos or larvae that exhibited the Pun phenotype.
Again, these results were reproducible with other independently
generated arrays and when analogous crosses were performed in
the sup-37 mutant background
qRT–PCR
Strains were grown at 16uC and total RNA from bleached
embryos was isolated using the Trizol reagent (Invitrogen)
followed by phenol-chloroform extraction. All samples were
DNase (Invitrogen ) treated and cleaned using the RNeasy Midi
Kit (Qiagen). cDNA was synthesized using random primers and
Superscript reverse transcriptase II (Invitrogen) at 42uC for
1 hour. First-strand cDNA was purified using the Qiagen
Microelute Kit and eluted in 10 l final volume.
Primer pairs used for the various genes include pha-1 [59-
TCGACTGGAGCTTCGTGTAAGTCA-39 and 59-ACGGTG-
CAAGGGCATTAAGGAAAC-39]; ama-1 [59-TGATGTGAT-
GACTGCGAAGGGACA-39 and 59-TTCGAATGAACAACG-
CATCAGGGC-39]; act-1 [59-TTACTCTTTCACCACCACCGC-
TGA-39 and 59-TCGTTTCCGACGGTGATGACTTGT-39]; and
sup-35 [59-GATCATGCGAGCGGTTATTCGTC-39 and 59-
GATCGATGGACTTCTCTCCAGAA-39]. All primer pairs am-
plified regions that spanned sizeable introns such that cDNA
amplification was strongly favored. Furthermore, we did not detect
genomic contamination in our cDNA samples based on several tests
including gel-purified amplimer band sizes. Primer pairs used for the
act-1 internal normalization are predicted to amplify act-1–3. Primer
pairs used for the ama-1 were specific to this gene. qRT-PCR was
performed using a BioRad icycler in a total reaction volume of 50 l
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conditions: initial denaturation at 95uC for 3 min, followed by 40
cycles of denaturation at 95uC for 30 seconds and a combined
annealing and extension step at 60uC for 30 seconds. After the final
amplification cycle, a melt curve analysis was performed to examine
the specificity of the reaction. The fold-change of the mRNA levels
was calculated by the delta-delta Ct method For each qRT-PCR
experiment, amplification was done in triplicate for both the test and
the normalization genes, and the results were checked for
reproducibility using at least one biological duplicate. In addition,
all data were reproduced using at least two biological replicates. P
values were determined using a Student’s t-test.
Immunoprecipitation and western blotting
Mixed-stage worms from 10 large NGM-OP50 plates were
pooled and washed with M9 and distilled water and resuspended
in 500 ml of homogenization buffer (20 mM Tris-HCl pH 7.5,
100 mM NaCl, 5 mM MgCl2, 1 mM EGTA, 1 mM DTT, 1%
TritonX-100, protease inhibitors). Worms were then sonicated,
incubated on ice, and lysates were cleared of large particles by
centrifugation. To immunoprecipitate SUP-35::GFP, precleared
worm lysate was incubated with 5 mg of polyclonal anti-GFP
antibody (Santa Cruz) at 4uC for 2 hrs and the resulting immune
complex was pulled down using 30 ml of proteinA-sepharose beads
(Invitrogen) by over-night incubation at 4uC. Beads were washed
36with cold homogenization buffer and subjected to SDS-PAGE
and western blot analysis. Westerns to detect ubiquitinated
products were carried out using either 2 mg of monoclonal anti-
ubiquitin antibody (Santa Cruz) or 2 mg of monoclonal anti-GFP
primary antibody (Invitrogen). Visualization was carried out using
HRP-conjugated goat anti-mouse secondary antibodies (Santa
Cruz) at 1:5000 and peroxidase activity was detected by the
enhanced chemiluminesence assay (Pierce). LLnL-treated Jurkat
cell lysate (Santa Cruz) was used as a positive control for
ubiquitination.
Supporting Information
Figure S1 Quantification of PHA-1::GFP (A and B) and Ppha-
1::GFP (C and D) fluorescence intensities in individual embryos in
N2 (A and C) and sup-35(tm1810) mutant backgrounds (B and D).
Found at: doi:10.1371/journal.pgen.1000510.s001 (0.20 MB TIF)
Figure S2 Quantification of SUP-35::GFP fluorescence intensi-
ties in individual embryos following treatment of strains with
vector RNAi (A), lin-35(RNAi) (B), ubc-18(RNAi) (C), and ari-
1(RNAi) (D).
Found at: doi:10.1371/journal.pgen.1000510.s002 (0.23 MB TIF)
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